Production (Stage)
Eloxx Pharmaceuticals, Inc.
ELOX
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 32.46% | -9.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.15% | -24.49% | |||
| Operating Income | 12.15% | 24.49% | |||
| Income Before Tax | 17.25% | 30.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.25% | 30.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.25% | 30.32% | |||
| EBIT | 12.15% | 24.49% | |||
| EBITDA | 12.21% | 24.51% | |||
| EPS Basic | 33.38% | 31.77% | |||
| Normalized Basic EPS | 28.64% | 27.01% | |||
| EPS Diluted | 33.24% | 31.77% | |||
| Normalized Diluted EPS | 28.64% | 27.01% | |||
| Average Basic Shares Outstanding | 24.20% | 2.12% | |||
| Average Diluted Shares Outstanding | 24.20% | 2.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||